SEATTLE, June 21, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global embolization market is estimated to be valued at US$ 1,433.6 million in 2020 and is expected to exhibit a CAGR of 8.1% over the forecast period (2020-2027).
Key Trends and Analysis of the Global Embolization Market:
The increasing number of product approvals, product launches, and collaborations and partnerships strategies adopted by key players are the major factors, which are expected to drive the market growth over the forecast period.
For instance, in 2018, Cerenovus, a division of Johnson & Johnson (US), launched its Galaxy G3 mini coil (embolization product) for use in the endovascular treatment of cerebral aneurysms and hemorrhagic stroke. Moreover, in 2018, Medtronic Plc. launched its OptiSphere embolization spheres in the U.S. The OptiSphere resorbable embolic platform is designed for embolization of hyper vascular tumors.
Furthermore, in 2019, Guerbet received CE mark approval for SeQure and DraKon, two novel microcatheters, for peripheral embolization procedures.
Request for Sample copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/4473
The increasing research and development of innovative embolization products for the treatment of various chronic diseases is expected to drive the market growth during the forecast period. For instance, in April 2018, Embolx, Inc., a medical device company, announced that the company has been awarded a Small Business Innovation Research (SBIR) grant valued at US$ 2 million from the National Cancer Institute (NCI) of the National Institutes of Health (NIH). The SBIR grant will fund further for research and development of Embolx’s future generation Sniper balloon occlusion microcatheter, an innovative system for pressure-directed embolization therapy.
Key Market Takeaways:
The global embolization market is expected to exhibit a CAGR of 8.1% over the forecast period, owing to increasing product launches. For instance, in 2017, Medtronic Plc. launched Concerto 3D detachable coil system at the Cardiovascular and Interventional Radiological Society of Europe annual meeting in Copenhagen, Denmark. This coil is indicated for arterial and venous embolization in the peripheral vasculature.
Competitive Landscape:
Key players operating in the global embolization market include IMBiotechnologies Ltd., ABK Biomedical Inc., EmboMedics, Guerbet, Boston Scientific Corporation, Medtronic Plc., Varian Medical Systems, Inc., Terumo Corporation, Merit Medical Systems, Inc., Cook Group, and Johnson & Johnson
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4473
Market Segmentation:
- Global Embolization Market, By Product Type:
- Particles
- Radioembolization Spheres
- Drug-eluting Beads
- Microspheres (or Blands beads, without drug)
- PVA particles (Polyvinyl Alcohol)
- Liquid Embolic
- Plugs
- Coils
- Particles
- Global Embolization Market, By Indication:
- Hemorrage/Bleeding
- Benign Prostatic Hyperplasia (BPH)
- Uterine Fibroid
- Tumor (Malignant, including Liver Cancer)
- Malformation (AVM, AVF)
- Venous embolization (incl. Varicocele for ex)
- Others
- Global Embolization Market, By End User:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
- Global Embolization Market, By Region:
- North America
- By Country
- U.S.
- Canada
- By Country
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- By Country
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- By Country
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- By Country
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- By Country
- Africa
- By Country/Region
- South Africa
- Central Africa
- North Africa
- By Country/Region
- North America
Related Market Intelligence Reports:
Embolization Particle Market, by Product type (Radioembolization Spheres, Microspheres, Drug Eluting Beads, PVA Particles & Gelfoam Particles, and Other Particles), by Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others), by End User (Hospitals & Clinics, Ambulatory Centers, and Others) and by Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) — Size, Share, Outlook, and Opportunity Analysis, 2018–2026
Read more: https://www.coherentmarketinsights.com/ongoing-insight/embolization-particle-market-2374
Interventional Oncology Ablation Market, by Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, and Irreversible Electroporation Ablation), by Indication (Liver Cancer, Kidney Cancer, Lung Cancer, and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 – 2027
Read more: https://www.coherentmarketinsights.com/market-insight/interventional-oncology-ablation-market-4445
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide.